CDH1 and cancer: The E-cadherin protein, produced by the CDH1 gene, may be inactivated in human malignant tumors via various processes, including somatic mutations, genetic abnormalities, activation of transcriptional repressors, abnormal protein processing, and promoter hypermethylation.